DARE - Dare Bioscience - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DARE is currently covered by 3 analysts with an average price target of $15.56. This is a potential upside of $13.43 (630.52%) from yesterday's end of day stock price of $2.13.

Dare Bioscience's activity chart (see below) currently has 6 price targets and 17 ratings on display. The stock rating distribution of DARE is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 250.67 days.

Highest price target for DARE is $12, Lowest price target is $12, average price target is $9.33.

Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 01-Apr-2025. First documented stock forecast 17-Aug-2018.

Currently out of the existing stock ratings of DARE, 9 are a BUY (90%), 1 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$9.85 (458.14%)

$12

5 months 9 days ago
(01-Apr-2025)

0/5 (0%)

$9.1 (313.79%)

Buy

$13

$10.85 (504.65%)

1 years 25 days ago
(16-Aug-2024)

0/1 (0%)

$9.43 (264.15%)

Hold

$4

1 years 27 days ago
(14-Aug-2024)

1/1 (100%)

$-15.44 (-79.42%)

660

Buy

$3

$0.09 (3.09%)

1 years 3 months 27 days ago
(15-May-2024)

2/2 (100%)

$-1.32 (-30.56%)

135

Buy

$2

$-0.15 (-6.98%)

2 years 11 days ago
(30-Aug-2023)

1/1 (100%)

$-6.52 (-76.53%)

709

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DARE (Dare Bioscience) average time for price targets to be met?

On average it took 250.67 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on DARE (Dare Bioscience) with a proven track record?

KEMP DOLLIVER

Which analyst has the current lower performing score on DARE (Dare Bioscience) with a proven track record?

CATHERINE NOVACK

Which analyst has the most public recommendations on DARE (Dare Bioscience)?

Kemp Dolliver works at BROOKLINE and has 1 price targets and 2 ratings on DARE

Which analyst is the currently most bullish on DARE (Dare Bioscience)?

Catherine Novack with highest potential upside - $10.85

Which analyst is the currently most reserved on DARE (Dare Bioscience)?

Jason Kolbert with lowest potential downside - -$0.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?